Trial Profile
Imaging Tau Deposition in the Brain of Elderly Subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Nov 2023
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Mild cognitive impairment
- Focus Diagnostic use
- Acronyms Add-Tau
- 21 Dec 2021 Planned End Date changed from 1 Nov 2028 to 1 Dec 2029.
- 21 Dec 2021 Planned primary completion date changed from 1 Jun 2023 to 1 Dec 2024.
- 21 Dec 2021 Status changed from recruiting to active, no longer recruiting.